Post-COVID-19 Chronic Fatigue Syndrome

• Status: Not yet recruiting
• Trial end date: 2023-05-08
• Target enrollment: 0
• Participant gender: All

Summary

Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ClinAmygate
• Collaborator: As-Salam Center, Maadi, Cairo, Egypt
• Treatments: Thiamine

Criteria

Inclusion Criteria:

• Age . 18

• Male or female

• Post-Covid-19 Fatigue

Exclusion Criteria:

• refusal